Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | -4.42% | -1.82% | +24.86% |
Business Summary
Number of employees: 325
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drugs
100.0
%
| 157 | 100.0 % | 146 | 100.0 % | -7.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 157 | 100.0 % | 146 | 100.0 % | -7.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Accumanno James
CMP | Compliance Officer | - | 21-04-30 |
Reshma Rangwala
CTO | Chief Tech/Sci/R&D Officer | 46 | 22-03-31 |
Elhan Webb
IRC | Investor Relations Contact | - | 22-03-13 |
Lisa DiPaolo
HRO | Human Resources Officer | - | 22-08-31 |
Stuart Poulton
PRN | Corporate Officer/Principal | 51 | 22-01-31 |
Sohanya Cheng
PRN | Corporate Officer/Principal | 41 | 21-06-07 |
Michael Mano
LAW | General Counsel | 47 | 20-12-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 | |
Chen Schor
BRD | Director/Board Member | 51 | 20-11-24 |
Mansoor Mirza
BRD | Director/Board Member | 63 | 10-09-30 |
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Christy Oliger
BRD | Director/Board Member | 54 | 20-08-27 |
Su Zhen
BRD | Director/Board Member | 47 | 23-08-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 116,465,736 | 111,318,522 ( 95.58 %) | 0 | 95.58 % |
Company contact information
Karyopharm Therapeutics, Inc.
85 Wells Avenue Suite 210, 2nd floor
02459-3298, Newton
+617 658 0600
http://www.karyopharm.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.86% | 127M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.18% | 22.19B | |
-16.16% | 21.33B | |
-6.82% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- KPTI Stock
- Company Karyopharm Therapeutics Inc.